HK1149956A1 - Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex - Google Patents

Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex

Info

Publication number
HK1149956A1
HK1149956A1 HK11103810A HK11103810A HK1149956A1 HK 1149956 A1 HK1149956 A1 HK 1149956A1 HK 11103810 A HK11103810 A HK 11103810A HK 11103810 A HK11103810 A HK 11103810A HK 1149956 A1 HK1149956 A1 HK 1149956A1
Authority
HK
Hong Kong
Prior art keywords
colorectal cancer
calprotectin
hemoglobin
stool sample
haptoglobin complex
Prior art date
Application number
HK11103810A
Other languages
English (en)
Inventor
Johann Karl
Ursula Garczarek
Norbert Wild
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1149956A1 publication Critical patent/HK1149956A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4727Calcium binding proteins, e.g. calmodulin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805Haemoglobins; Myoglobins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK11103810A 2007-11-20 2011-04-15 Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex HK1149956A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07022448 2007-11-20
PCT/EP2008/009733 WO2009065551A1 (en) 2007-11-20 2008-11-18 Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex

Publications (1)

Publication Number Publication Date
HK1149956A1 true HK1149956A1 (en) 2011-10-21

Family

ID=40134824

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103810A HK1149956A1 (en) 2007-11-20 2011-04-15 Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex

Country Status (8)

Country Link
US (2) US20110129860A1 (xx)
EP (1) EP2212700B8 (xx)
JP (1) JP5227418B2 (xx)
CN (1) CN101868729B (xx)
AT (1) ATE521894T1 (xx)
CA (1) CA2701341C (xx)
HK (1) HK1149956A1 (xx)
WO (1) WO2009065551A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5700392B2 (ja) * 2010-03-29 2015-04-15 独立行政法人国立高等専門学校機構 生体試料の調製法
ES2380664B2 (es) 2010-10-19 2012-09-13 Certest Biotec, S.L. Método y dispositivo para el diagnóstico rápido de enfermedades en muestras fecales.
GB201021509D0 (en) * 2010-12-20 2011-02-02 Reactivlab Ltd Assay method
US10072300B2 (en) 2013-05-21 2018-09-11 Biomerieux Kit for the prognosis of colorectal cancer
EP2947459B1 (en) * 2014-05-21 2017-07-12 Bühlmann Laboratories AG Method for determination of a protein
AU2016211113A1 (en) 2015-01-30 2017-09-07 Enterome Host DNA as a biomarker of Crohn's disease
CN104614371A (zh) * 2015-02-15 2015-05-13 史春龙 一种在便器中检测排泄物生化指标的方法及使用该方法的检测设备
EP3281016A1 (en) 2015-04-10 2018-02-14 Applied Proteomics Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
WO2017146647A1 (en) * 2016-02-22 2017-08-31 Agency For Science, Technology And Research Method for detecting an analyte using surface enhanced raman spectroscopy
AU2017275081B2 (en) 2016-05-30 2023-12-07 Eiken Kagaku Kabushiki Kaisha Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same
CN106814189B (zh) * 2016-12-20 2018-10-26 成都金思唯生物技术有限公司 一种检测艰难梭菌的试剂盒及其用途
CN108333368A (zh) * 2018-02-07 2018-07-27 深圳市伯劳特生物制品有限公司 一种检测人粪便中钙卫蛋白的试剂盒及制备方法
CN112578123B (zh) * 2019-09-27 2022-10-25 成都中医药大学 检测粪钙卫蛋白含量的试剂在制备子宫病变筛查试剂盒中的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198365A (en) * 1987-02-04 1993-03-30 International Immunoassay Laboratories, Inc. Fecal sample immunoassay method testing for hemoglobin
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
DE69731103T2 (de) * 1996-11-01 2005-11-17 Fagerhol, Magne K., Dr. Verfahren zur proteinextraktion
AUPP713498A0 (en) * 1998-11-17 1998-12-10 Chandler, Howard Milne A method of detecting blood
WO2002080775A1 (en) * 2001-04-04 2002-10-17 Enterix Inc. Method of collecting a gastrointestinal tract sample
JP2004251851A (ja) * 2003-02-21 2004-09-09 Japan Clinical Laboratories Inc 糞便成分の検査方法
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment
JP2009520957A (ja) * 2005-12-21 2009-05-28 エフ.ホフマン−ラ ロシュ アーゲー 便試料中のヘモグロビンおよびm2−pkを測定することによる結腸直腸癌の評価方法
JP4942813B2 (ja) * 2006-05-19 2012-05-30 エフ.ホフマン−ラ ロシュ アーゲー 結腸直腸癌のマーカーとしてのタンパク質s100a12の使用
JP2010526995A (ja) * 2007-05-10 2010-08-05 エフ.ホフマン−ラ ロシュ アーゲー 結腸直腸癌のマーカーとしてのtimp−1の使用

Also Published As

Publication number Publication date
EP2212700A1 (en) 2010-08-04
CN101868729B (zh) 2013-07-17
EP2212700B8 (en) 2011-10-12
ATE521894T1 (de) 2011-09-15
JP2011503593A (ja) 2011-01-27
EP2212700B1 (en) 2011-08-24
CN101868729A (zh) 2010-10-20
US20110129860A1 (en) 2011-06-02
US20150126401A1 (en) 2015-05-07
JP5227418B2 (ja) 2013-07-03
CA2701341A1 (en) 2009-05-28
CA2701341C (en) 2012-03-20
WO2009065551A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
HK1149956A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
ATE554389T1 (de) Apex als marker für lungenkrebs
IN2013CN01129A (xx)
WO2010096154A3 (en) Compositions and methods for diagnosis and prognosis of colorectal cancer
SI1721162T1 (sl) Postopek za ugotavljanje revmatoidnega artritisa z merjenjem anti-CCP in serumskega amiloida A
ATE535612T1 (de) Toxizitätsscreeningverfahren
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
WO2011021041A3 (en) Survival prognostic assay
WO2005064307A3 (en) Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6
DK2185939T3 (da) Engangsanalyseudstyr med mikroprocessor
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
WO2010000467A8 (en) Asc as a marker for lung cancer
MX2012000041A (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
NZ601643A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
GB2456690A (en) A method for quantitative detection of diabetes related immunological markers
GB201105295D0 (en) Cancer detection

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171118